Search Result "lasmiditan"
Targeting to 5-HT1F Receptor Subtype for Migraine Treatment: Lessons from the Past, Implications for the Future
Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 12 Issue: 4 Year: 2012 Page: 241-249
Author(s): Dimos D. Mitsikostas,Peer Tfelt-Hansen
The Journey of the Non-Vascular Relief for Migraine: From âTriptansâ To âDitansâ
Journal: Current Clinical Pharmacology
Volume: 12 Issue: 1 Year: 2017 Page: 36-40
Author(s): Alphienes S. Xavier,Mageshwaran Lakshmanan,Vikneswaran Gunaseelan
Safety and Efficacy of Calcitonin Gene-related Peptide ReceptorAntagonists and Selective Serotonin Receptor Agonist in the Managementof Migraine: A Systematic Review and Meta-analysis
Journal: CNS & Neurological Disorders - Drug Targets
Volume: 23 Issue: 12 Year: 2024 Page: 1474-1487
Author(s): Rakesh Kumar Ponnada
New Therapeutic Options for Migraine
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 25 Year: 2023 Page: 1964-1966
Author(s): Maria Adele Giamberardino
The Role of 5-Hydroxytryptamine in the Pathophysiology of Migraine and its Relevance to the Design of Novel Treatments
Journal: Mini-Reviews in Medicinal Chemistry
Volume: 17 Issue: 11 Year: 2017 Page: 928-938
Author(s): Carlos M. Villalón,Antoinette Maassen VanDenBrink
Editorial: [Hot Topic: Central Nervous System Drugs in the Treatment of Neurological Disorders]
Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 12 Issue: 3 Year: 2012 Page: 153-157
Author(s): Mohtashem Samsam
Global Epidemiology, Clinical Features, Diagnosis and Current TherapeuticNovelties in Migraine Therapy and their Prevention: A Narrative Review
Journal: Current Pharmaceutical Design
Volume: 29 Issue: 41 Year: 2023 Page: 3295-3311
Author(s):
Clinical Pharmacology of Current and Future Drugs for the Acute Treatment of Migraine: A Review and An Update
Journal: Current Clinical Pharmacology
Volume: 7 Issue: 1 Year: 2012 Page: 66-72
Author(s): Peer Tfelt-Hansen
Central Nervous System Acting Drugs in Treatment of Migraine Headache
Journal: Central Nervous System Agents in Medicinal Chemistry
Volume: 12 Issue: 3 Year: 2012 Page: 158-172
Author(s): Mohtashem Samsam
THE SEROTONERGIC SYSTEM AS A TARGET FOR POSITRON EMISSION TOMOGRAPHY LIGANDS APPLICATIONS IN AFFECTIVE DISORDERS
Ebook: Neurobiology of Mood Disorders
Volume: 1 Year: 2014
Author(s): ANNIEK K.D. VISSER,AREN VAN WAARDE,FOKKO J. BOSKER,JOHAN A. DEN BOER,RUDI A. DIERCKX
Doi: 10.2174/9781608054671114010006